Patients with a diagnosis of invasive ductal carcinoma at the time of sample retrieval had significantly elevated mean galectin-3 levels compared to patients with ductal carcinoma in situ histology. The gene discussed is LGALS3; the disease is ductal breast carcinoma in situ.